The Iranian man and founder of the organization known as the Keshe Foundation, who claims to be a nuclear physicist and sells his plasma products which he says can cure HIV/AIDS, diabetes and other diseases, Mehran Tavakoli Keshe has been convicted of fraud and given a suspended sentence by a Belgian court. His wife, Carolina De Roos was also sentenced by the same court that sat in the Belgian city of Kortrijk, according to news sources out of Belgium yesterday, August 9, 2017.
Keshe was given an 18 months sentence and the wife 12 months. The two currently live in Italy.
The couple was charged for deceiving Belgian citizens that they can be healed of various ailments when they drink water from special thermos bottles and inhale air through an inhaler which Keshe sells.
The reports indicate that Keshe’s claims to heal with his plasma water came to the attention of the country’s medical regulatory authorities in 2012. The couple was also cited for practicing medicine illegally in Belgium.
Court investigations revealed that Keshe and his wife were scammers and confiscated an amount of €15,000 which it said was made from the fraudulent sale of the plasma water.
The news reports said eight victims of the couple were identified in areas among others in Roeselare, Meulebeke, Waregem, Anzegem and Ninove.
Keshe in Ghana
Meanwhile, a little over a week ago, Keshe was in Ghana to hold a press conference where according to some local news accounts and there are different accounts, he claims he is investing $15 million in scientific technology and he will build the first space launch pad in Africa in Ghana, a claim he made in May 2017 during a conference that he organised in Ghana under the auspices of the Ghana Atomic Energy Commission.
The Commission, however, which signed an MoU with the Keshe Foundation has abrogated the deal on the grounds that Keshe’s claims cannot be scientifically proven.
Another newspaper account says he is investing $750 million to build a plant in Ghana to start producing his range of plasma products.
Other reports say, he will create 3000 jobs for scientists with his plant.
But the Minister for Science and Environment, Prof Kwabena Frimpong-Boateng has questioned Keshe’s credibility and claims of being a nuclear physicist.
Prof. Frimpong-Boateng said after some scrutiny, it was found that the activities Keshe, his predictions and medicinal product purported to cure certain diseases were not genuine.
In response to the Ministers comments, Keshe issued threats, making veiled threats that he knows the Minister was hiding money in Dubai. But the Minister was swift in responding that he has never been to Dubai.
Sources familiar with Keshe’s modus operandi say the only was he responds to his critics is to slander them.
In some of the Keshe Foundation’s live streaming of its leader’s lectures, Keshe makes claims that staff of the Ghana Food and Drugs Authority (FDA) and the Ghana Standards Board use his products and testify to their efficacy, but a check on the FDA website where a list of approved medical and food products are published doesn’t have any product from the Keshe Foundation listed.
Keshe and the 20 Ghanaian scientists
Keshe appears to have some chips under his sleeves in his quest to keep his hold on Ghana. He currently has 20 graduates of the Graduate School of Nuclear Sciences that he has hired to work for him under the now abrogated MoU with the Atomic Commission. Their future is unclear.
The Director-General of the Ghana Atomic Energy Commission, Prof. Benjamin J. B. Nyarko who is currently attending a meeting in Vienna, Austria, told ghanabusinessnews.com on the phone Thursday morning that, the graduates of the school can’t find jobs and they are free to work in the private sector if they can find jobs.
Asked about the future of the 20 graduates working with the Keshe Foundation, he suggested that they should be advised to leave the Foundation.
It does not appear that Ghana has seen the last of Keshe yet.
By Emmanuel K. Dogbevi
Copyright ©2017 by Creative Imaginations Publicity
All rights reserved. This news item any portion thereof may not be reproduced or used in any manner whatsoever without the express written permission of the publisher except for the use of brief quotations in reviews.